AMENDMENT NO. 1 TO RESEARCH AGREEMENT This Amendment No. 1 to Research Agreement ("Amendment") is made and entered into as of November 15, 2002 by and between BioCell Innovations ("Sponsor") and The University of Texas M.D. Anderson Cancer Center...Research Agreement • December 13th, 2002 • Regenetech Inc
AGREEMENT THIS AGREEMENT made in triplicate and effective as of the date of execution by the last party hereto. BETWEEN: THE GOVERNMENT OF THE UNITED STATES OF AMERICA (hereinafter referred to as "Government") AND: CJAB Associates LLP, a partnership...Intellectual Property License Agreement • December 13th, 2002 • Regenetech Inc
BIOCELL INNOVATIONS, INC. AND GLEN ODOMEmployment Agreement • December 13th, 2002 • Regenetech Inc • Texas
PARTIALLY EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNITED STATES OF AMERICA REPRESENTED BY THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION ANDPartially Exclusive License Agreement • December 13th, 2002 • Regenetech Inc
LOCK-UP AGREEMENT In connection with a stock offering under SB-2 of the Securities Act of 1933, as amended, conducted by a company in which I hold a substantial and founding interest, I agree to "Lock-Up" such securities for a period of twelve months...Lock-Up Agreement • December 13th, 2002 • Regenetech Inc
In connection with a stock offering under SB-2 of the Securities Act of 1933, as amended, conducted by a company in which I hold a substantial and founding interest, I agree to "Lock-Up" such securities for a period of twelve months (365) days from the date of the end of the offering period. Specifically, I agree that I will not sell all or any portion of my holdings during that period without prior written approval of the Underwriter, Three Arrows Capital Corp. The company in which I hold such shares is ReGeneTech, Inc. and the estimated completion date of the offering is on or before February 15, 2004.
UNDERWRITING & SELLING AGREEMENT In regard to the offerings being made by BioCell Innovations, Inc. (BCI), or successors, in a stock offering under the Securities Act of 1933 or an exemption, direct or indirect investment, merger or acquisition, BCI...Underwriting Agreement • December 13th, 2002 • Regenetech Inc
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT, executed this 4th day of December, 2002 and except as specified herein, is effective as of the Effective Date, is entered into by and between REGENETECH, INC., a Texas corporation (the "Regenetech"), and...Employment Agreement • December 13th, 2002 • Regenetech Inc • Texas
1. PROTOCOLSponsored Laboratory Study Agreement • December 13th, 2002 • Regenetech Inc • Texas
CONSULTING AGREEMENT This Agreement is made on May 31, 2002 between BioCell Innovations, Inc. (the "Company") with offices and principal place of business at 6302 Tall Canyon Court, Katy, Texas 77450 and Zeev Estrov, MD (the "Consultant"), residing at...Consulting Agreement • December 13th, 2002 • Regenetech Inc
